HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Annki Pålbrink Selected Research

cilostamide

8/2019Endolymphatic hydrops induced by different mechanisms responds differentially to spironolactone: a rationale for understanding the diversity of treatment responses in hydropic inner ear disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Annki Pålbrink Research Topics

Disease

2Endolymphatic Hydrops
08/2019 - 01/2017
1Ear Diseases (Disease, Ear)
08/2019
1Edema (Dropsy)
08/2019
1Labyrinth Diseases
08/2019

Drug/Important Bio-Agent (IBA)

1Spironolactone (Aldactone)FDA LinkGeneric
08/2019
1Vasopressins (Vasopressin)IBA
08/2019
1cilostamideIBA
08/2019
1RolipramIBA
08/2019
1Phosphodiesterase 5 InhibitorsIBA
01/2017
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
01/2017